Compare General Mills, Inc. (GIS) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
General Mills, Inc. vs Tempus AI — how do they compare? General Mills, Inc. trades at $32.37 (market cap $17.43B), while Tempus AI trades at $70.19 (market cap $12.77B). The key difference: General Mills, Inc. is the larger of the two by market cap, and General Mills, Inc. pays a 7.49% dividend while Tempus AI pays none. Which is the better fit depends on your goals — on Pluang, investors hold General Mills, Inc. for 106 Days and Tempus AI for 22 Days on average.
| GIS | TEM | |
|---|---|---|
Market Cap | $17.43B | $12.77B |
Volume | 16,554,362 | 8,980,490 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $49.36 | $99.28 |
52-Week Low | $31.67 | $41.55 |
Typical Hold Time | 106 Days | 22 Days |
Enterprise Value | $30.61B | $13.40B |
Dividend Yield | 7.49% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
General Mills (GIS) trades at $31.77, down 1.27% on the day, with a bearish technical signal and mixed earnings performance. The stock shows attractive valuation ratios like a P/E of 9.23 and P/S of 0.93, but profitability metrics are weak with a negative net income margin and ROE. Recent news highlights a CEO transition and a 22% stock decline last month amid revenue and profit pressures.
The outlook is cautious; while the dividend yield is appealing and cost-saving initiatives are in place, declining revenue, margin compression, and high debt levels pose significant risks. Analyst consensus is mixed with a $36 price target, but bearish sentiment and competitive pressures suggest limited near-term upside.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
